Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Effectiveness of daratumumab plus bortezomib, lenalidomide, and dexamethasone (DVRd) versus VRd for transplant-eligible newly diagnosed multiple myeloma.
Journal: Future oncology (London, England)
Published: July 14, 2026
Incidence and Associated Risk Factors in the Development of Carfilzomib-Induced Cardiovascular Toxicity.
Journal: Current oncology (Toronto, Ont.)
Published: June 22, 2026
From episodic assessment to comprehensive assessment: integrating real-world monitoring in relapsed/refractory multiple myeloma.
Journal: Expert review of hematology
Published: May 27, 2026
The ClinicalTrials.gov Landscape of Multiple Myeloma Clinical Trials: A 20-Year Analysis of Geographic Distribution and Growth Patterns: USMIRC Analysis.
Journal: Current oncology (Toronto, Ont.)
Published: May 05, 2026
Two Decades of Light-Chain Amyloidosis: Real-World Trends in Diagnosis, Treatment, and Survival.
Journal: Journal of hematology
Published: March 19, 2026
Evaluation of Real-World Studies on Management of Relapsed Multiple Myeloma After BCMA-Directed Therapy Failure from U.S. Academic Centers and USMIRC.
Journal: Current oncology (Toronto, Ont.)
Published: March 17, 2026
High-Risk Cytogenetic Multiple Myeloma Remains a Therapeutic Challenge: A 15-Year Real-World Analysis.
Journal: Current oncology (Toronto, Ont.)
Published: March 11, 2026
Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible Patients.
Journal: Current oncology (Toronto, Ont.)
Published: March 09, 2026
Maintenance Strategies in High-Risk Myeloma: A Multicenter Comparison of Bortezomib-Lenalidomide Versus Lenalidomide Alone: A USMIRC Multicenter Analysis.
Journal: Current oncology (Toronto, Ont.)
Published: January 30, 2026
A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment-USMIRC Group.
Journal: Cancers
Published: December 12, 2025
Delayed Diagnosis of Poems Syndrome, How AI Tools Can Enhance Diagnostic Accuracy.
Journal: European journal of case reports in internal medicine
Published: May 06, 2025
Real-World Outcomes of Sequential BCMA-directed therapies in Relapsed Refractory Multiple Myeloma After Belantamab Exposure.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 07, 2025
Last Updated: 09/26/2026